Workflow
Life Settlement Policies
icon
Search documents
Abacus Refutes Misleading Balance Sheet Claims With Independent Third-Party Actuarial Valuation
Globenewswireยท 2025-06-10 12:30
Core Viewpoint - Abacus Global Management strongly refutes the allegations made in a short seller's report, asserting that the claims regarding its reliance on a single life expectancy provider and inflated balance sheet valuation are incorrect [2][22]. Group 1: Response to Short Seller Allegations - The short seller's report claims that Abacus relies too heavily on Lapetus Solutions for life expectancy estimates, which the company denies, stating that it does not depend on Lapetus for portfolio valuation [2][6]. - Abacus engaged Lewis and Ellis, a third-party actuarial firm, to validate its policy balance sheet, confirming that the valuation of $449 million as of March 31, 2025, aligns closely with its own reported valuation of $446 million [9][6]. - The company emphasizes that its valuation methodology incorporates a mark-to-market approach, which is based on actual market transactions rather than solely on life expectancy estimates [12][10]. Group 2: Valuation Methodology - Abacus employs a dual valuation approach: life expectancy estimates for consumer-facing transactions and market-based valuations for balance sheet management, ensuring fair pricing and accurate asset valuation [10][11]. - The company prioritizes market reality in its trading portfolio, which allows for a more accurate reflection of asset value based on actual transaction history [20][12]. - Recent market transactions support the accuracy of Abacus's valuation model, with the company selling 226 policies for $141.4 million, closely matching the estimated balance sheet value of $139.1 million [15][16]. Group 3: Shareholder Commitment and Future Outlook - Abacus executives and shareholders collectively own approximately 46% of the outstanding shares, with a two-year lock-up period expiring on July 3, 2025, which is expected to positively impact the company's inclusion in the Russell 2000 and 3000 indices [17][19]. - The company asserts that the expiration of the lock-up period is not an opportunity for large shareholders to cash out but rather a chance to drive the company towards its next milestones [18][19]. - Abacus is committed to transparent communication with shareholders regarding any future share sales, emphasizing its long-term dedication to increasing shareholder value [20][21].